Related Experiment Videos

Methaemoglobin levels during nitroglycerin infusion for the intraoperative induction of controlled hypotension

Arzneimittel-Forschung
|January 1, 1983
PubMed

Insights

Intravenous nitroglycerin infusion for controlled hypotension minimally increased methaemoglobin levels in patients. This study found no clinically significant methaemoglobinaemia at typical infusion rates.

Area of Science:

  • Cardiovascular Pharmacology
  • Anesthesiology
  • Hematology

Background:

  • Nitroglycerin is frequently used intraoperatively to induce controlled hypotension.
  • Potential adverse effects, such as methaemoglobinaemia, require careful monitoring.

Purpose of the Study:

  • To investigate methaemoglobin formation during intravenous nitroglycerin infusion for controlled hypotension.
  • To determine if nitroglycerin infusion leads to clinically significant methaemoglobinaemia.

Main Methods:

  • Intraoperative investigation in 46 patients receiving intravenous nitroglycerin for controlled hypotension.
  • Methaemoglobin concentrations measured pre-infusion, during, and 60 minutes post-infusion using an IL CO Oximeter 282.
  • Analysis of infusion rates (mean 3.50 ± 0.38 µg/kg/min) and duration (mean 87 ± 7.0 min).

Main Results:

  • Baseline methaemoglobin levels were 0.6 ± 0.1%.
  • Nitroglycerin infusion caused a maximum increase of approximately 1% in methaemoglobin levels.
  • No correlation observed between methaemoglobin increase, total nitroglycerin dose, or infusion rate.
  • Mean maximum methaemoglobin level reached 0.9 ± 0.2%.

Conclusions:

  • Intravenous nitroglycerin infusion at average rates up to 10 µg/kg/min does not induce clinically significant methaemoglobinaemia.
  • The observed methaemoglobin increase is minimal and not dose-dependent.
  • Nitroglycerin can be safely administered for controlled hypotension without significant risk of methaemoglobinaemia.

Related Concept Videos